SCYX Q2 2017 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$7M-10539.1% margin

Net Income

-$4M-6560.9% margin

EPS (Diluted)

$-1.63

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$437,000

Balance Sheet

Total Assets

$52M

Total Liabilities

$20M

Stockholders' Equity

$32M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$7M	-$8M	+18.4%
Net Income	-$4M	-$8M	+48.3%